Effect of Octreotide on Saliva
NCT05340192
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
4
Enrollment
OTHER
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Octreotide 1 MG/ML
Sponsor
Duke University